朗科科技(300042.SZ):擬關停合資公司韶關朗正
格隆匯9月26日丨朗科科技(300042.SZ)公佈,韶關朗正數據半導體有限公司(以下簡稱"韶關朗正")為深圳市朗科科技股份有限公司(以下簡稱"公司")與正源芯半導體(深圳)有限公司(以下簡稱"正源芯")於2022年12月設立的合資公司,主要從事存儲芯片封裝測試業務。由於訂單不足,韶關朗正自成立以來營業收入較少並持續虧損,公司結合行業發展狀況,決定對韶關朗正進行關停。本次關停事項對公司營業收入影響較小,有利於國有資產保值,切實維護公司及全體股東的利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.